Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.


Lumira Ventures Participates In The Closing of PIC Therapeutics $35 Million Series A Financing to Develop Treatments for Drug-Resistant Breast Cancer

October 19, 2022
Financing Round Led by OrbiMed with participation from Lumira Ventures, Harrington Discovery Institute and existing investors Advent Life Sciences and Belinda Termeer Therapy development focused... Learn More

DAMONA Pharmaceuticals Raises US$5.5 Million Seed Stage Financing to Advance Lead Molecule Development to Treat Cognitive Deficits Associated with Depression and Diseases of Aging

September 26, 2022
TORONTO, Ontario, September 26, 2022 -- DAMONA Pharmaceuticals today announced the closing of a seed stage financing round to support the development of its lead therapeutic for the treatment of... Learn More

X4 Pharmaceuticals Announces $55 Million Private Placement Financing and Debt Facility Amendment Extending Interest-Only Period by up to 12 Months

July 26, 2022
X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel CXCR4 targeted small molecule therapeutics to benefit people with rare immune system disorders, today... Learn More

Lumira Ventures Builds Upon Presence in Western Canada with Partner Lu Han, Ph.D. Expanding Firm’s Vancouver Office

June 15, 2022
TORONTO, Ontario, June 14, 2022 -- Lumira Ventures, a global healthcare venture capital firm, announced today that Partner Lu Han Ph.D. has relocated to the firm’s office in Vancouver, British... Learn More

Team Lumira

Our investment team of 12 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.



Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.

  • "Lumira's philanthropic vision of leveraging research, resources and knowledge to improve the lives of patients will strengthen St. Michael's ability to accelerate the pace."

    Dr. Arthur Slutsky | Vice-President
    Vice-President of Research at St. Michael's Hospital
  • "Lumira's model provides a new pathway for philanthropy to partner with investors in advancing healthcare innovation."

    Barbara Grantham | President & Ceo
    VGH & UBC Hospital Foundation
  • “This distinctive approach to supporting innovation is very creative, very much needed and very much appreciated by Princess Margaret and University Health Network.”

    Paul Alofs | President & Ceo
    Princess Margaret Cancer Foundation

Contact Us

Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.



141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5



Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7



1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3



303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208